Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Affinity, specificity and T-cell-receptor diversity of melanoma-specific CTL generated in vitro against a single tyrosinase epitope.
Visseren MJ, van der Burg SH, Hawes GE, van der Voort EI, van den Elsen PJ, Melief CJ. Visseren MJ, et al. Among authors: van der burg sh, van der voort ei, van den elsen pj. Int J Cancer. 1997 Sep 17;72(6):1122-8. doi: 10.1002/(sici)1097-0215(19970917)72:6<1122::aid-ijc30>3.0.co;2-3. Int J Cancer. 1997. PMID: 9378549 Free article.
Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product.
Visseren MJ, van der Burg SH, van der Voort EI, Brandt RM, Schrier PI, van der Bruggen P, Boon T, Melief CJ, Kast WM. Visseren MJ, et al. Among authors: van der burg sh, van der voort ei, van der bruggen p. Int J Cancer. 1997 Sep 26;73(1):125-30. doi: 10.1002/(sici)1097-0215(19970926)73:1<125::aid-ijc19>3.0.co;2-f. Int J Cancer. 1997. PMID: 9334819 Free article.
Lysis of syngeneic tumor B cells by autoreactive cytotoxic T lymphocytes specific for a CD19 antigen-derived synthetic peptide.
Hooijberg E, Visseren MJ, van den Berk PC, Jellema AP, Romeijn P, Sein JJ, van der Voort EI, Hekman A, Ossendorp F, Melief CJ. Hooijberg E, et al. Among authors: van den berk pc, van der voort ei. J Immunother Emphasis Tumor Immunol. 1996 Sep;19(5):346-56. doi: 10.1097/00002371-199609000-00004. J Immunother Emphasis Tumor Immunol. 1996. PMID: 8941874
Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.
Vierboom MP, Nijman HW, Offringa R, van der Voort EI, van Hall T, van den Broek L, Fleuren GJ, Kenemans P, Kast WM, Melief CJ. Vierboom MP, et al. Among authors: van den broek l, van hall t, van der voort ei. J Exp Med. 1997 Aug 29;186(5):695-704. doi: 10.1084/jem.186.5.695. J Exp Med. 1997. PMID: 9271585 Free PMC article.
Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion.
Toes RE, Hoeben RC, van der Voort EI, Ressing ME, van der Eb AJ, Melief CJ, Offringa R. Toes RE, et al. Among authors: van der eb aj, van der voort ei. Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14660-5. doi: 10.1073/pnas.94.26.14660. Proc Natl Acad Sci U S A. 1997. PMID: 9405669 Free PMC article.
46 results